Breaking News Instant updates and real-time market news.

AZN

AstraZeneca

$33.26

0.865 (2.67%)

, TEVA

Teva

$32.79

-0.396 (-1.19%)

13:58
07/14/17
07/14
13:58
07/14/17
13:58

AstraZeneca up 4% after Bloomberg says CEO plans on staying

Shares of Teva (TEVA) are down 4% to $31.97.

AZN

AstraZeneca

$33.26

0.865 (2.67%)

TEVA

Teva

$32.79

-0.396 (-1.19%)

  • 19

    Jul

  • 03

    Aug

  • 30

    Aug

AZN AstraZeneca
$33.26

0.865 (2.67%)

07/05/17
SBSH
07/05/17
DOWNGRADE
SBSH
Neutral
GlaxoSmithKline downgraded to Neutral from Buy at Citi
Citi analyst Andrew Baum downgraded GlaxoSmithKline (GSK) to Neutral and lowered his price target for the shares to GBP 17 from GBP 18. The analyst believes the market is underappreciating the slowing of the company's HIV market growth. He prefers shares of AstraZeneca (AZN), Roche (RHHBY) and Bayer (BAYRY) for exposure to Europe.
07/13/17
LEER
07/13/17
NO CHANGE
LEER
Outperform
AstraZeneca CEO departure now would have 'terrible' optics, says Leerink
Leerink analyst Seamus Fernandez said the media report that AstraZeneca (AZN) CEO Pascal Soriot may be leaving the company to take over at Teva (TEVA) comes as a "major surprise," adding that while the company would not comment to him on the rumor it also did not outright deny the report. While the news does not appear to be related to the outcome of the MYSTIC trial in non-small cell lung cancer, the optics around such a departure at this would be "terrible" and his loss would be a "clear negative" for AstraZeneca, according to Fernandez, who has an Outperform rating on Astra shares.
07/13/17
SBSH
07/13/17
NO CHANGE
Target $42
SBSH
Buy
Teva landing Soriot would be 'material positive,' says Citi
Citi analyst Liav Abraham believes Calcalist's report of Teva (TEVA) hiring away AstraZeneca's (AZN) CEO Pascal Soriot has credibility given the "relatively accurate track record" of the Israeli press in the "leaking" of information pertaining to Teva. The news, if confirmed, would be a "material positive" for Teva over the near to medium term, Abraham tells investors in a research note. She believes Soriot would "lend significant credibility" to Teva's turnaround thesis. On the other side, Soriot leaving would increase concerns over the pending outcome of AstraZeneca's MYSTIC trial, which constitutes the dominant near-term driver for the shares, Abraham argues. She has a Buy rating on Teva with a $42 price target. The stock in premarket trading is up 2% to $32.80. AstraZeneca is down 14c to $32.78.
07/14/17
LEER
07/14/17
NO CHANGE
Target $36
LEER
Outperform
Leerink sees significant optionality for AstraZeneca beyond MYSTIC trial
Leerink analyst Seamus Fernandez said he sees significant optionality for AstraZeneca (AZN) beyond the "mega-catalyst" of the MYSTIC trial in non-small cell lung cancer, as he believes several 2017 and 2018 readouts from underappreciated pipeline assets could lead to upside for the shares. If MYSTIC fails, Astra's "massive" SG&A spend gives it flexibility to mute the bottom-line impact. If it is successful, he believes potential acquirers such as Pfizer (PFE) or Novartis (NVS) could see "an attractive target to plunder," Fernandez tells investors. He keeps an Outperform rating and $36 price target on AstraZeneca ADRs.
TEVA Teva
$32.79

-0.396 (-1.19%)

06/27/17
WELS
06/27/17
NO CHANGE
WELS
Market Perform
Teva TV-45070 trial miss a 'modest disappointment,' says Wells Fargo
Wells Fargo analyst David Maris said TV-45070 has not been a focus for Teva (TEVA) investors, but he still views the news that the company and partner Xenon Pharmaceuticals' (XENE) Phase 2 trial in post-herpetic neuralgia missed its primary endpoint as a "modest disappointment" given the need for Teva's pipeline to offset the tough generic market and the eventual competition for Copaxone. Maris keeps a Market Perform rating on Teva.
07/05/17
OPCO
07/05/17
NO CHANGE
Target $70
OPCO
Outperform
Neurocrine Ingrezza 'holds steady' after competitor data, says Oppenheimer
Oppenheimer analyst Jay Olson notes that Teva's (TEVA) Austedo could become a competitor to Neurocrine's (NBIX) Ingrezza with a PDUFA date for the tardive dyskinesia indication on August 30, 2017. However, the analyst sees Ingrezza as well positioned and reiterates an Outperform rating and $70 price target on Neurocrine's shares. A key factor to follow beyond the short trials will be real-life performance considering the number needed to treat to observe a 50% AIMS improvement was 5 for Austedo and 4 for Ingrezza, he contends.

TODAY'S FREE FLY STORIES

08:45
11/21/18
11/21
08:45
11/21/18
08:45
General news
U.S. durable goods orders dropped 4.4% in October »

U.S. durable goods orders…

BGS

B&G Foods

$30.69

0.44 (1.45%)

, GGB

Gerdau

$4.11

-0.19 (-4.42%)

08:45
11/21/18
11/21
08:45
11/21/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

BGS

B&G Foods

$30.69

0.44 (1.45%)

GGB

Gerdau

$4.11

-0.19 (-4.42%)

CRON

Cronos Group

$8.19

-0.05 (-0.61%)

QID

ProShares UltraShort QQQ

$46.41

1.57 (3.50%)

SSO

ProShares Ultra S&P 500

$104.01

-4.03 (-3.73%)

NEPT

Neptune Wellness

$3.10

-0.125 (-3.88%)

NFX

Newfield Exploration

$17.67

-1.69 (-8.73%)

CVX

Chevron

$116.19

-3.23 (-2.70%)

EWY

iShares MSCI South Korea Index Fund

$58.89

-1.05 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

08:45
11/21/18
11/21
08:45
11/21/18
08:45
General news
Treasury Action: yields ebbed to lows »

Treasury Action: yields…

08:45
11/21/18
11/21
08:45
11/21/18
08:45
General news
U.S. initial jobless claims rose 3k in the week ended November 17 to 224k »

U.S. initial jobless…

BW

Babcock & Wilcox

$0.90

-0.0052 (-0.58%)

08:41
11/21/18
11/21
08:41
11/21/18
08:41
Conference/Events
Babcock & Wilcox to host conference call »

As previously announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$793.73

-35.77 (-4.31%)

08:40
11/21/18
11/21
08:40
11/21/18
08:40
Recommendations
AutoZone analyst commentary  »

AutoZone price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

MUFG

Mitsubishi UFJ

$5.56

-0.005 (-0.09%)

08:40
11/21/18
11/21
08:40
11/21/18
08:40
Periodicals
U.S. prosecutors probing Mitsubishi UFJ money laundering controls, NY Times says »

Mitsubishi UFJ Financial,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSX

Diana Shipping

$3.06

-0.11 (-3.47%)

08:40
11/21/18
11/21
08:40
11/21/18
08:40
Hot Stocks
Diana Shipping announces time charter contract for m/v Alcmeme with BG Shipping »

Diana Shipping announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

08:40
11/21/18
11/21
08:40
11/21/18
08:40
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

SOLO

ElectraMeccanica

$1.39

-0.12 (-7.95%)

08:38
11/21/18
11/21
08:38
11/21/18
08:38
Hot Stocks
ElectraMeccanica CFO Kulwant Sandher to depart, Bal Bhullar to succeed »

ElectraMeccanica…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 04

    Dec

LOW

Lowe's

$86.15

-5.19 (-5.68%)

08:36
11/21/18
11/21
08:36
11/21/18
08:36
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMB

Limbach Holding

$4.85

-1.04 (-17.66%)

, FIX

Comfort Systems USA

$52.64

-1.06 (-1.97%)

08:35
11/21/18
11/21
08:35
11/21/18
08:35
Recommendations
Limbach Holding, Comfort Systems USA, Emcore analyst commentary  »

Limbach Holding price…

LMB

Limbach Holding

$4.85

-1.04 (-17.66%)

FIX

Comfort Systems USA

$52.64

-1.06 (-1.97%)

EMKR

Emcore

$4.42

-0.02 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:34
11/21/18
11/21
08:34
11/21/18
08:34
General news
Jobless Claims data reported »

Week of 11/17 Jobless…

DXCM

DexCom

$119.89

-1.34 (-1.11%)

, GOOG

Alphabet

$1,026.00

7 (0.69%)

08:33
11/21/18
11/21
08:33
11/21/18
08:33
Recommendations
DexCom, Alphabet, Alphabet Class A analyst commentary  »

Verily collaboration more…

DXCM

DexCom

$119.89

-1.34 (-1.11%)

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

LUXTY

Luxottica

$0.00

(0.00%)

08:31
11/21/18
11/21
08:31
11/21/18
08:31
Downgrade
Luxottica rating change  »

Luxottica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGCO

Agco

$57.86

0.5 (0.87%)

, DE

Deere

$138.49

-4.04 (-2.83%)

08:29
11/21/18
11/21
08:29
11/21/18
08:29
Hot Stocks
Agco drops 2% after Deere issues FY19 guidance »

Shares of farm equipment…

AGCO

Agco

$57.86

0.5 (0.87%)

DE

Deere

$138.49

-4.04 (-2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

USCR

U.S. Concrete

$34.14

-1.6 (-4.48%)

08:25
11/21/18
11/21
08:25
11/21/18
08:25
Recommendations
U.S. Concrete analyst commentary  »

U.S. Concrete price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

HUM

Humana

$307.50

-2.87 (-0.92%)

, WBA

Walgreens Boots Alliance

$79.82

-2.11 (-2.58%)

08:25
11/21/18
11/21
08:25
11/21/18
08:25
Recommendations
Humana, Walgreens Boots Alliance, Amazon.com, CVS Health, Aetna, UnitedHealth analyst commentary  »

Humana-Walgreens…

HUM

Humana

$307.50

-2.87 (-0.92%)

WBA

Walgreens Boots Alliance

$79.82

-2.11 (-2.58%)

AMZN

Amazon.com

$1,495.60

-16.07 (-1.06%)

CVS

CVS Health

$75.52

-3.02 (-3.85%)

AET

Aetna

$204.15

-3.535 (-1.70%)

UNH

UnitedHealth

$261.52

-4.52 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 02

    Dec

  • 04

    Dec

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:21
11/21/18
11/21
08:21
11/21/18
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
11/21/18
11/21
08:20
11/21/18
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
11/21/18
11/21
08:20
11/21/18
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JEC

Jacobs Engineering

$65.06

-7.9 (-10.83%)

08:20
11/21/18
11/21
08:20
11/21/18
08:20
Recommendations
Jacobs Engineering analyst commentary  »

Jacobs Engineering shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 19

    Feb

IYT

iShares Transportation Average

$184.16

-5.75 (-3.03%)

08:20
11/21/18
11/21
08:20
11/21/18
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
11/21/18
11/21
08:20
11/21/18
08:20
General news
U.S. Durable Goods Preview »

U.S. Durable Goods…

08:20
11/21/18
11/21
08:20
11/21/18
08:20
General news
U.S. initial jobless claims preview: »

U.S. initial jobless…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.